Bodycote publishes scheme document and sets vote for Bodycote stock

Published on 10/06/2026 at 09:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

The scheme needs 75.00 percent approval by value on October 21, 2026. Bodycote stock had a EUR 10.80 prior close on October 5, 2026.

Architektonisches 3D-Render eines modernen Industriegebäudes mit Silos und Laderampen — Modernes Architektur-Render einer Industrieanlage mit Glasfassade und Silos, thematisch zu Bodycote plc, ISIN GB00B3FLWH99, Illustration mit AI erstellt.

Bodycote (ISIN GB00B3FLWH99) published a scheme document on September 28, 2026, setting out the recommended cash acquisition by Veritas Capital. The Court Meeting and General Meeting are scheduled for October 21, 2026, making shareholder approval the immediate event for Bodycote stock.

Approval requires a clear threshold

According to Investegate on September 28, 2026, the scheme requires approval by a majority in number of participating scheme shareholders representing at least 75.00 percent by value of the shares voted at the Court Meeting. A separate special resolution must also pass at the General Meeting.

The Court Meeting is scheduled for 10:00 a.m. London time on October 21, 2026, followed by the General Meeting at 10:15 a.m. The proxy deadline is October 19, 2026, according to Investegate.

Veritas now has a clearer path

Reuters reported on September 28, 2026, that CVC Advisers would not make an offer, clearing the way for Veritas Capital's GBP 1.85 billion takeover offer including debt. Reuters also reported that Veritas had increased its proposal to GBp 940 per share earlier in September.

The transaction still depends on shareholder and court approval. The scheme is expected to become effective in the first quarter of 2027, after which Bodycote shares are intended to leave the London Stock Exchange, according to Investegate.

Half-year earnings add operating context

For the six months ended June 30, 2026, Bodycote revenue rose 3.00 percent to GBP 381.2 million, while net income increased 12.00 percent to GBP 31.0 million, according to Patria. Specialist Technologies revenue increased 15.00 percent to GBP 121.2 million, compared with 2.00 percent growth in Precision Heat Treatment to GBP 250.8 million.

That mix matters because the faster-growing Specialist Technologies division contributed a larger operating profit increase than the group average. The earnings figures provide a business backdrop while the takeover timetable determines the next decisive shareholder event.

Bodycote stock awaits the shareholder vote

Bodycote's prior close at Lang & Schwarz was EUR 10.80 on October 5, 2026. The London-listed share's finance quote showed a 52-week range of GBp 585.00 to GBp 967.50 as of October 5, 2026, placing the current reference in the upper part of that range.

The further course of trading is shown by the continuously updated real-time quote of Bodycote stock.